Physician profile
Peter A Ferrante
NPI 1417344607
$4,866.60
in general payments reported to CMS, 2019-2025
28 companies · $1,040 in 2025
The $1,040 reported for 2025 was more than what 81% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $427 · 2020: $720 · 2021: $731 · 2022: $466 · 2023: $553 · 2024: $930 · 2025: $1,040.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,523.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,522.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $1,146.07 | 2020-2025 | Affinity, Apligraf, Cygnus Dual |
| Smith+Nephew, INC. | $556.76 | 2019-2025 | Renasys Touch, Grafix Pl, Stravix |
| Reapplix INC. | $477.61 | 2022-2025 | 3c Patch Kit - Box |
| Stryker Corporation | $465.44 | 2019-2024 | Ortholoc 3di Crosscheck |
| Paratek Pharmaceuticals, INC. | $387.62 | 2021-2025 | Nuzyra |
| Convatec INC. | $313.03 | 2019-2023 | |
| Solventum Corporation | $201.70 | 2024-2025 | Activ.A.C., Prevena, 3m Cavilon |
| Misonix INC | $180.98 | 2019-2020 | |
| Urgo Medical North America, LLC | $150.07 | 2023-2024 | Drawtex Hydroconductive Wound Dressing With Levafiber 4x4, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2 |
| Kci USA, INC. | $144.26 | 2020-2023 | Promogran Prisma, Tegaderm, Kerramax Care |
| Hydrofera LLC | $116.83 | 2022-2025 | Hydrofera Blue, Hydrofera Blue Ready - Border |
| Janssen Pharmaceuticals, INC | $95.61 | 2021 | |
| Avita Medical Americas, LLC | $93.15 | 2025 | Cohealyx, Recell, Permeaderm |
| Horizon Therapeutics Plc | $87.96 | 2020-2021 | |
| Musculoskeletal Transplant Foundation INC. | $72.89 | 2021 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $58.99 | 2020-2024 | Tcc-Ez |
| Grt US Holding, INC. | $57.67 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $52.71 | 2019 | |
| Next Science LLC | $36.74 | 2023-2025 | Blastx, Xperience, Surgx |
| Pfizer INC. | $34.95 | 2019 | |
| Abbvie INC. | $25.69 | 2024 | |
| Nabriva Therapeutics, Plc | $24.98 | 2020-2021 | |
| Lifenet Health | $20.53 | 2023 | |
| Osiris Therapeutics INC. | $15.26 | 2019 | |
| Bioventus LLC | $13.81 | 2019 | |
| Axogen | $12.67 | 2019 | |
| Sandoz INC. | $11.59 | 2020 | |
| Bsn Medical INC | $11.03 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Ferrante listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.